SCHEMBL7694906

SCHEMBL7694906

Cc1cc(C)n(-c2nnc(NNc3nnc(-n4nc(C)cc4C)nn3)nn2)n1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.70
RAB9A P51151 3/20 0.70
NPC1 O15118 3/20 0.70
MAPT P10636 6/20 0.57
HTT P42858 5/20 0.57
L3MBTL1 Q9Y468 4/20 0.57
MAPK1 P28482 3/20 0.57
ALOX15 P16050 4/20 0.51
CYP1A2 P05177 2/20 0.51
CYP2C9 P11712 2/20 0.51
KMT2A Q03164 2/20 0.51
CYP2C19 P33261 2/20 0.51
NPSR1 Q6W5P4 2/20 0.51
LMNA P02545 1/20 0.51
USP2 O75604 1/20 0.49
POLB P06746 1/20 0.49
PTPN7 P35236 1/20 0.49
CREBBP Q92793 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
RECQL P46063 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3712068 0.88 RAB9A (0.67) SMN1; SMN2RAB9ANPC1MAPTHTT
SCHEMBL27926814 0.85 SMN1; SMN2 (0.66) SMN1; SMN2RAB9ANPC1MAPTHTT
SCHEMBL17468789 0.82 RAB9A (0.61) SMN1; SMN2RAB9ANPC1MAPTHTT
SCHEMBL27863664 0.80 CYP1A2 (0.65) SMN1; SMN2RAB9ANPC1MAPTHTT
SCHEMBL17482192 0.79 SMN1; SMN2 (0.70) SMN1; SMN2RAB9ANPC1MAPTHTT
SCHEMBL17482180 0.78 SMN1; SMN2 (0.57) SMN1; SMN2RAB9ANPC1MAPTHTT
SCHEMBL3780684 0.78 HTT (0.61) SMN1; SMN2RAB9ANPC1MAPTHTT
SCHEMBL27863645 0.77 SMN1; SMN2 (0.50) SMN1; SMN2RAB9ANPC1MAPTHTT
SCHEMBL31655490 0.76 SMN1; SMN2 (0.55) SMN1; SMN2RAB9ANPC1MAPTHTT
SCHEMBL3661523 0.76 SMN1; SMN2 (0.54) SMN1; SMN2RAB9ANPC1MAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6342589-B1 REACTING 3,6-BIS(3,5-DIMETHYLPYRAZOL-1-YL)-1,2,4,5-TETRAZINE WITH HYDRAZINE; FURTHER REACTING WITH N-BROMOSUCCINIMIDE IN ACETONITRILE THE UNITED STATES OF AMERICA AS REPRESENTED BY THE UNITED STATES DEPARTMENT OF ENERGY 2002-01-29 US disclosed